Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer

Journal of Radiation Research

Volumn 55, Issue 1, 2014, Pages 146-153

  Suzuki, Minoru ^a   Kato, Ituro ^c   Aihara, Teruhito ^d   Hiratsuka, Junichi ^d   Yoshimura, Kenichi ^e   Niimi, Miyuki ^e   Kimura, Yoshihiro ^f   Ariyoshi, Yasunori ^a   Haginomori, Shin Ichi ^f   Sakurai, Yoshinori ^b   Kinashi, Yuko ^b   Masunaga, Shin Ichiro ^a   Fukushima, Masanori ^e   Ono, Koji ^a   Maruhashi, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

^f OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

boron neutron capture therapy; head and neck tumors

Indexed keywords

DISEASES; NEUTRONS; PATIENT TREATMENT;

BORON NEUTRON CAPTURE THERAPY; BORON NEUTRONCAPTURE THERAPY; CAROTID ARTERY; CLINICAL OUTCOME; FOLLOW UP; HEAD CANCER; HEAD-AND-NECK CANCER; HEAD-AND-NECK TUMOR; NECK CANCER; ORAL MUCOSA;

TOXICITY;

ADULT; AGED; EPIDEMIOLOGY; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; NEUTRON CAPTURE THERAPY; PREVALENCE; RADIATION DOSE; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BORON NEUTRON CAPTURE THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84892715177     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt098     Document Type: Review

References (20)

1. Haraf DJ, Weichselbaum RR, Vokes EE. Reirradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 1996;7:913-8.
2. Spencer SA, Harris J, Wheeler RH et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 2008;30:281-8.
3. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res 1999;151:1-18.
4. Kato I, Ono K, Sakurai Y et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 2004;61:1069-73.
5. Kankaanranta L, Seppälä T, Koivunoro H et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys 2012;82:e67-75.
6. Aihara T, Hiratsuka J, Morita N et al. First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. Head Neck 2006;28:850-5.
7. Nigg DW, Wemple CA, Wessol DE et al. SERA-an advanced treatment planning system for neutron capture therapy and BNCT. Trans Am Nucl Soc 1999;80:66-8.
8. Suzuki M, Sakurai Y, Masunaga S et al. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors. Int J Radiat Oncol Biol Phys 2004; 58:892-6.
9. Salama JK, Vokes EE, Chmura SJ et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2006;64:382-91.
10. De Crevoisier R, Bourhis J, Domenge C et al. Full-dose reirra-diation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 1998;16:3556-62.
11. Langer CJ, Harris J, Horwitz EM et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 2007;25:4800-5.
12. Spencer SA, Wheeler R, Peters G et al. Phase 1 trial of combined chemotherapy and reirradiation for recurrent unre-sectable head and neck cancer. Head Neck 2003;25: 118-22.
13. Spencer SA, Harris J, Wheeler RH et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 2008;30:281-8.
14. Schaefer U, Micke O, Schueller P et al. Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. Radiology 2000;216:371-6.
15. Weppelmann B, Wheeler RH, Peters GE et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int J Radiat Oncol Biol Phys 1992;22: 1051-6.
16. Kramer NM, Horwitz EM, Cheng J et al. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck 2005;27:406-14.
17. Hehr T, Classen J, Belka C et al. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. Int J Radiat Oncol Biol Phys 2005;61:1423-31.
18. Cohen EE, Rosine D, Haraf DJ et al. Phase I trial of tirapaza-mine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007;67:678-84.
19. Sulman EP, Schwartz DL, Le TT et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009;73:399-409.
20. Roh KW, Jang JS, Kim MS et al. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2009;74:1348-55.